VMO1: A Potential Drug Target for Various Diseases (G284013)

Target Name: VMO1

NCBI ID: G284013

VMO1

VMO1: A Potential Drug Target for Various Diseases

VMO1 (MGC125880) is a protein that is expressed in various tissues of the body, including the brain, lungs, heart, and gastrointestinal tract. It is a member of the VOM-related gene (VOM-G) family , this family includes multiple transcription factors, such as VMO1, VMO2, VMO3 and VMO4. VMO1 plays an important role in a variety of physiological processes, including cell proliferation, differentiation, and tumorigenesis.

The expression level of VMO1 is regulated in different tissues and biological processes. During embryonic development, VMO1 expression levels gradually decrease as the neural tube differentiates. In adults, the expression level of VMO1 is affected by a variety of physiological and pathological factors, such as age, gender, lifestyle, and disease.

The function and mechanism of action of VMO1 are not fully understood. Currently, researchers mainly study the role of VMO1 in tumorigenesis, cell cycle and signal transduction through experimental methods. For example, some studies have shown that the expression level of VMO1 is positively correlated with the prognosis of various cancers, such as lung cancer, liver cancer, gastric cancer, etc. In addition, studies have shown that the expression level of VMO1 is related to neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and Alzheimer's disease.

Because VMO1 plays an important role in a variety of physiological processes, it is considered a potential drug target. Currently, researchers are exploring VMO1 as a potential drug to treat a variety of diseases. For example, some studies have shown that inhibitors of VMO1 can inhibit the proliferation and metastasis of tumor cells, thus having anti-tumor effects. In addition, inhibitors of VMO1 can also regulate the cell cycle and inhibit the growth and spread of tumor cells, thus having anti-tumor effects.

In addition, VMO1 is also closely related to the occurrence and development of various diseases. For example, some studies have found that the expression level of VMO1 is related to various neurodegenerative diseases, such as Parkinson's disease, Alzheimer's disease, and multiple sclerosis. In addition, the expression level of VMO1 is also related to various cardiovascular diseases, such as hypertension, myocardial infarction and stroke.

In summary, VMO1 is an important protein that plays an important role in a variety of physiological and pathological processes. By studying the biological functions and mechanisms of action of VMO1, its potential and role in the treatment of various diseases can be revealed, and new ideas and methods can be provided for the treatment of diseases.

Protein Name: Vitelline Membrane Outer Layer 1 Homolog

The "VMO1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about VMO1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets